Back to Search
ELIZABETH PINARD, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1346483252IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
30194(OK)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
OTHER
Class of 2009
Research & Publications (20)
Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
PMID 19542319·Mol Pharmacol·2009
4-observational
Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
PMID 18805008·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
PMID 18752953·Bioorg Med Chem Lett·2008
8-other
Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice.
PMID 17562813·Radiology·2007
7-preclinical
Vascular fate of adipose tissue-derived adult stromal cells in the ischemic murine brain: A combined imaging-histological study.
PMID 17056275·Neuroimage·2007
7-preclinical
Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier.
PMID 16864659·J Exp Med·2006
7-preclinical
4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters.
PMID 16762550·Bioorg Med Chem Lett·2006
7-preclinical
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: achieving selectivity against the mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors.
PMID 16762548·Bioorg Med Chem Lett·2006
8-other
Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability.
PMID 16757170·Bioorg Med Chem Lett·2006
7-preclinical
In vivo imaging with cellular resolution of bone marrow cells transplanted into the ischemic brain of a mouse.
PMID 16516498·Neuroimage·2006
7-preclinical
The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.
PMID 16481323·J Biol Chem·2006
7-preclinical
Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profile.
PMID 16246561·Bioorg Med Chem Lett·2006
8-other
Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors.
PMID 16246557·Bioorg Med Chem Lett·2006
8-other
Long-term in vivo investigation of mouse cerebral microcirculation by fluorescence confocal microscopy in the area of focal ischemia.
PMID 15758950·J Cereb Blood Flow Metab·2005
7-preclinical
The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore.
PMID 12952973·J Biol Chem·2003
7-preclinical
1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists.
PMID 12951084·Bioorg Med Chem Lett·2003
7-preclinical
4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists.
PMID 12729659·Bioorg Med Chem Lett·2003
7-preclinical
2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.
PMID 12617901·Bioorg Med Chem Lett·2003
7-preclinical
Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
PMID 12183650·J Pharmacol Exp Ther·2002
7-preclinical
4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.
PMID 12182873·Bioorg Med Chem Lett·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11200 N PORTLAND AVE
OKLAHOMA CITY, OK 73120 - Phone
- (405) 936-1000
Quick Facts
- NPI
- 1346483252
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile